nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Ovarian disorder—Bupropion—obesity	0.0314	0.0683	CcSEcCtD
Gonadorelin—Ceruletide—CCKAR—obesity	0.0232	0.851	CrCbGaD
Gonadorelin—Menopause—Bupropion—obesity	0.0214	0.0465	CcSEcCtD
Gonadorelin—Breast pain female—Topiramate—obesity	0.0213	0.0464	CcSEcCtD
Gonadorelin—Ovarian cyst—Bupropion—obesity	0.0199	0.0433	CcSEcCtD
Gonadorelin—GNRHR—hindbrain—obesity	0.0185	0.576	CbGeAlD
Gonadorelin—Dysmenorrhoea—Diethylpropion—obesity	0.012	0.0262	CcSEcCtD
Gonadorelin—Pelvic pain—Sibutramine—obesity	0.00915	0.0199	CcSEcCtD
Gonadorelin—GNRHR—pituitary gland—obesity	0.00765	0.239	CbGeAlD
Gonadorelin—Abdominal discomfort—Diethylpropion—obesity	0.00659	0.0143	CcSEcCtD
Gonadorelin—Contusion—Sibutramine—obesity	0.00638	0.0139	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Orlistat—obesity	0.00633	0.0138	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Sibutramine—obesity	0.00612	0.0133	CcSEcCtD
Gonadorelin—GNRHR—endocrine gland—obesity	0.00593	0.185	CbGeAlD
Gonadorelin—Contusion—Bupropion—obesity	0.00556	0.0121	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Methamphetamine—obesity	0.0054	0.0117	CcSEcCtD
Gonadorelin—Constipation—Methamphetamine—obesity	0.00535	0.0116	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Bupropion—obesity	0.00534	0.0116	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Benzphetamine—obesity	0.0052	0.0113	CcSEcCtD
Gonadorelin—Haematoma—Topiramate—obesity	0.00492	0.0107	CcSEcCtD
Gonadorelin—Embolism—Topiramate—obesity	0.00482	0.0105	CcSEcCtD
Gonadorelin—Erythema—Diethylpropion—obesity	0.00479	0.0104	CcSEcCtD
Gonadorelin—Constipation—Phendimetrazine—obesity	0.0047	0.0102	CcSEcCtD
Gonadorelin—Hypersensitivity—Methamphetamine—obesity	0.00461	0.01	CcSEcCtD
Gonadorelin—Redness—Topiramate—obesity	0.00458	0.00997	CcSEcCtD
Gonadorelin—Flatulence—Cimetidine—obesity	0.00449	0.00977	CcSEcCtD
Gonadorelin—Hypersensitivity—Benzphetamine—obesity	0.00444	0.00967	CcSEcCtD
Gonadorelin—Abdominal pain—Phendimetrazine—obesity	0.00434	0.00945	CcSEcCtD
Gonadorelin—Diarrhoea—Methamphetamine—obesity	0.00428	0.00931	CcSEcCtD
Gonadorelin—Diarrhoea—Benzphetamine—obesity	0.00412	0.00898	CcSEcCtD
Gonadorelin—Constipation—Phenylpropanolamine—obesity	0.00401	0.00874	CcSEcCtD
Gonadorelin—Headache—Methamphetamine—obesity	0.00392	0.00852	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Phentermine—obesity	0.00388	0.00844	CcSEcCtD
Gonadorelin—Fatigue—Phentermine—obesity	0.00387	0.00843	CcSEcCtD
Gonadorelin—Constipation—Phentermine—obesity	0.00384	0.00836	CcSEcCtD
Gonadorelin—Headache—Benzphetamine—obesity	0.00378	0.00822	CcSEcCtD
Gonadorelin—Breast disorder—Orlistat—obesity	0.00377	0.00821	CcSEcCtD
Gonadorelin—Diarrhoea—Phendimetrazine—obesity	0.00376	0.00818	CcSEcCtD
Gonadorelin—Anaphylactic shock—Cimetidine—obesity	0.00372	0.00809	CcSEcCtD
Gonadorelin—Nausea—Benzphetamine—obesity	0.00358	0.00779	CcSEcCtD
Gonadorelin—Abdominal pain—Phentermine—obesity	0.00355	0.00773	CcSEcCtD
Gonadorelin—Breast pain—Topiramate—obesity	0.00354	0.00771	CcSEcCtD
Gonadorelin—Abdominal discomfort—Orlistat—obesity	0.00346	0.00753	CcSEcCtD
Gonadorelin—Hypersensitivity—Phenylpropanolamine—obesity	0.00346	0.00753	CcSEcCtD
Gonadorelin—Headache—Phendimetrazine—obesity	0.00344	0.00749	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Topiramate—obesity	0.0034	0.0074	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Diethylpropion—obesity	0.00337	0.00734	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Orlistat—obesity	0.00335	0.0073	CcSEcCtD
Gonadorelin—Constipation—Diethylpropion—obesity	0.00334	0.00727	CcSEcCtD
Gonadorelin—Pentagastrin—BCHE—obesity	0.0033	0.121	CrCbGaD
Gonadorelin—Nausea—Phendimetrazine—obesity	0.00326	0.0071	CcSEcCtD
Gonadorelin—Asthenia—Phentermine—obesity	0.00322	0.00701	CcSEcCtD
Gonadorelin—Fatigue—Cimetidine—obesity	0.00321	0.00698	CcSEcCtD
Gonadorelin—Breast disorder—Bupropion—obesity	0.00318	0.00693	CcSEcCtD
Gonadorelin—Constipation—Cimetidine—obesity	0.00318	0.00692	CcSEcCtD
Gonadorelin—Diarrhoea—Phentermine—obesity	0.00307	0.00669	CcSEcCtD
Gonadorelin—Vomiting—Phenylpropanolamine—obesity	0.00298	0.00649	CcSEcCtD
Gonadorelin—Abdominal discomfort—Bupropion—obesity	0.00292	0.00635	CcSEcCtD
Gonadorelin—Vomiting—Phentermine—obesity	0.00286	0.00622	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Bupropion—obesity	0.00283	0.00616	CcSEcCtD
Gonadorelin—Headache—Phentermine—obesity	0.00281	0.00612	CcSEcCtD
Gonadorelin—Nausea—Phenylpropanolamine—obesity	0.00279	0.00607	CcSEcCtD
Gonadorelin—Hypersensitivity—Cimetidine—obesity	0.00274	0.00596	CcSEcCtD
Gonadorelin—Diarrhoea—Diethylpropion—obesity	0.00267	0.00582	CcSEcCtD
Gonadorelin—Nausea—Phentermine—obesity	0.00267	0.00581	CcSEcCtD
Gonadorelin—Asthenia—Cimetidine—obesity	0.00267	0.00581	CcSEcCtD
Gonadorelin—Immune system disorder—Orlistat—obesity	0.00261	0.00568	CcSEcCtD
Gonadorelin—Diarrhoea—Cimetidine—obesity	0.00254	0.00554	CcSEcCtD
Gonadorelin—Angiopathy—Sibutramine—obesity	0.00254	0.00552	CcSEcCtD
Gonadorelin—Immune system disorder—Sibutramine—obesity	0.00253	0.0055	CcSEcCtD
Gonadorelin—Vomiting—Diethylpropion—obesity	0.00248	0.00541	CcSEcCtD
Gonadorelin—Flatulence—Orlistat—obesity	0.00248	0.00539	CcSEcCtD
Gonadorelin—Headache—Diethylpropion—obesity	0.00245	0.00533	CcSEcCtD
Gonadorelin—Flatulence—Sibutramine—obesity	0.0024	0.00522	CcSEcCtD
Gonadorelin—Vomiting—Cimetidine—obesity	0.00236	0.00514	CcSEcCtD
Gonadorelin—Headache—Cimetidine—obesity	0.00233	0.00507	CcSEcCtD
Gonadorelin—Nausea—Diethylpropion—obesity	0.00232	0.00505	CcSEcCtD
Gonadorelin—Angiopathy—Bupropion—obesity	0.00221	0.00481	CcSEcCtD
Gonadorelin—Nausea—Cimetidine—obesity	0.00221	0.00481	CcSEcCtD
Gonadorelin—Immune system disorder—Bupropion—obesity	0.0022	0.00479	CcSEcCtD
Gonadorelin—Flatulence—Bupropion—obesity	0.00209	0.00455	CcSEcCtD
Gonadorelin—Anaphylactic shock—Orlistat—obesity	0.00205	0.00447	CcSEcCtD
Gonadorelin—Breast disorder—Topiramate—obesity	0.00203	0.00441	CcSEcCtD
Gonadorelin—Nervous system disorder—Orlistat—obesity	0.00201	0.00438	CcSEcCtD
Gonadorelin—Anaphylactic shock—Sibutramine—obesity	0.00199	0.00432	CcSEcCtD
Gonadorelin—Shock—Sibutramine—obesity	0.00195	0.00425	CcSEcCtD
Gonadorelin—Abdominal discomfort—Topiramate—obesity	0.00186	0.00405	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Topiramate—obesity	0.0018	0.00392	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Orlistat—obesity	0.00177	0.00386	CcSEcCtD
Gonadorelin—Fatigue—Orlistat—obesity	0.00177	0.00385	CcSEcCtD
Gonadorelin—Pain—Orlistat—obesity	0.00176	0.00382	CcSEcCtD
Gonadorelin—Anaphylactic shock—Bupropion—obesity	0.00173	0.00377	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Sibutramine—obesity	0.00172	0.00373	CcSEcCtD
Gonadorelin—Shock—Bupropion—obesity	0.0017	0.00371	CcSEcCtD
Gonadorelin—Pain—Sibutramine—obesity	0.0017	0.0037	CcSEcCtD
Gonadorelin—Constipation—Sibutramine—obesity	0.0017	0.0037	CcSEcCtD
Gonadorelin—Nervous system disorder—Bupropion—obesity	0.0017	0.0037	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Orlistat—obesity	0.00168	0.00365	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Sibutramine—obesity	0.00162	0.00354	CcSEcCtD
Gonadorelin—Abdominal pain—Orlistat—obesity	0.00162	0.00353	CcSEcCtD
Gonadorelin—Abdominal pain—Sibutramine—obesity	0.00157	0.00342	CcSEcCtD
Gonadorelin—Hypersensitivity—Orlistat—obesity	0.00151	0.00329	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Bupropion—obesity	0.0015	0.00325	CcSEcCtD
Gonadorelin—Fatigue—Bupropion—obesity	0.00149	0.00325	CcSEcCtD
Gonadorelin—Pain—Bupropion—obesity	0.00148	0.00322	CcSEcCtD
Gonadorelin—Constipation—Bupropion—obesity	0.00148	0.00322	CcSEcCtD
Gonadorelin—Asthenia—Orlistat—obesity	0.00147	0.00321	CcSEcCtD
Gonadorelin—Hypersensitivity—Sibutramine—obesity	0.00146	0.00319	CcSEcCtD
Gonadorelin—Pruritus—Orlistat—obesity	0.00145	0.00316	CcSEcCtD
Gonadorelin—Asthenia—Sibutramine—obesity	0.00143	0.0031	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Bupropion—obesity	0.00142	0.00308	CcSEcCtD
Gonadorelin—Angiopathy—Topiramate—obesity	0.00141	0.00307	CcSEcCtD
Gonadorelin—Pruritus—Sibutramine—obesity	0.00141	0.00306	CcSEcCtD
Gonadorelin—Diarrhoea—Orlistat—obesity	0.0014	0.00306	CcSEcCtD
Gonadorelin—Immune system disorder—Topiramate—obesity	0.0014	0.00305	CcSEcCtD
Gonadorelin—Abdominal pain—Bupropion—obesity	0.00137	0.00298	CcSEcCtD
Gonadorelin—Diarrhoea—Sibutramine—obesity	0.00136	0.00296	CcSEcCtD
Gonadorelin—Erythema—Topiramate—obesity	0.00135	0.00294	CcSEcCtD
Gonadorelin—Flatulence—Topiramate—obesity	0.00133	0.0029	CcSEcCtD
Gonadorelin—Vomiting—Orlistat—obesity	0.00131	0.00284	CcSEcCtD
Gonadorelin—Headache—Orlistat—obesity	0.00129	0.0028	CcSEcCtD
Gonadorelin—Hypersensitivity—Bupropion—obesity	0.00128	0.00278	CcSEcCtD
Gonadorelin—Vomiting—Sibutramine—obesity	0.00126	0.00275	CcSEcCtD
Gonadorelin—Headache—Sibutramine—obesity	0.00124	0.00271	CcSEcCtD
Gonadorelin—Asthenia—Bupropion—obesity	0.00124	0.0027	CcSEcCtD
Gonadorelin—Pruritus—Bupropion—obesity	0.00123	0.00267	CcSEcCtD
Gonadorelin—Nausea—Orlistat—obesity	0.00122	0.00265	CcSEcCtD
Gonadorelin—Diarrhoea—Bupropion—obesity	0.00118	0.00258	CcSEcCtD
Gonadorelin—Nausea—Sibutramine—obesity	0.00118	0.00257	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—NPY5R—obesity	0.00112	0.00233	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PMCH—obesity	0.00112	0.00233	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HCRT—obesity	0.00112	0.00233	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NMU—obesity	0.00112	0.00233	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	0.00111	0.0023	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.00111	0.0023	CbGpPWpGaD
Gonadorelin—Vomiting—Bupropion—obesity	0.0011	0.0024	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—MKS1—obesity	0.0011	0.00228	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KIF7—obesity	0.0011	0.00228	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—NPS—obesity	0.00109	0.00227	CbGpPWpGaD
Gonadorelin—Shock—Topiramate—obesity	0.00109	0.00236	CcSEcCtD
Gonadorelin—Headache—Bupropion—obesity	0.00108	0.00236	CcSEcCtD
Gonadorelin—Nervous system disorder—Topiramate—obesity	0.00108	0.00235	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—MC3R—obesity	0.00108	0.00224	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NPY2R—obesity	0.00108	0.00224	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—MC4R—obesity	0.00108	0.00224	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NPY1R—obesity	0.00108	0.00224	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—HTR2C—obesity	0.00107	0.00223	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—DRD1—obesity	0.00107	0.00223	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PPY—obesity	0.00106	0.00219	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRB1—obesity	0.00104	0.00216	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCH—obesity	0.00104	0.00215	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GIP—obesity	0.00104	0.00215	CbGpPWpGaD
Gonadorelin—Nausea—Bupropion—obesity	0.00103	0.00224	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	0.00102	0.00213	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPY5R—obesity	0.00102	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NMU—obesity	0.00102	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HCRT—obesity	0.00102	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PMCH—obesity	0.00102	0.00212	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GHRL—obesity	0.00102	0.00211	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—DRD4—obesity	0.00101	0.0021	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRLH—obesity	0.00101	0.00209	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.00098	0.00204	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPY1R—obesity	0.000977	0.00203	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MC3R—obesity	0.000977	0.00203	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MC4R—obesity	0.000977	0.00203	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPY2R—obesity	0.000977	0.00203	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CNR1—obesity	0.000963	0.002	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PPY—obesity	0.000959	0.00199	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Topiramate—obesity	0.000953	0.00207	CcSEcCtD
Gonadorelin—Fatigue—Topiramate—obesity	0.000951	0.00207	CcSEcCtD
Gonadorelin—Pain—Topiramate—obesity	0.000944	0.00205	CcSEcCtD
Gonadorelin—Constipation—Topiramate—obesity	0.000944	0.00205	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—GIP—obesity	0.000941	0.00196	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCH—obesity	0.000941	0.00196	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—DRD2—obesity	0.00094	0.00195	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GCG—obesity	0.00093	0.00193	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3R1—obesity	0.000909	0.00189	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Topiramate—obesity	0.000902	0.00196	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB3—obesity	0.000881	0.00183	CbGpPWpGaD
Gonadorelin—Abdominal pain—Topiramate—obesity	0.000872	0.0019	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000864	0.0018	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000863	0.00179	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GAL—obesity	0.000861	0.00179	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—C5AR1—obesity	0.000851	0.00177	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—ADRB2—obesity	0.000842	0.00175	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NMB—obesity	0.000833	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHRH—obesity	0.000833	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	0.000828	0.00172	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.00082	0.0017	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Topiramate—obesity	0.000813	0.00177	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	0.000813	0.00169	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GNB3—obesity	0.000802	0.00167	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB3—obesity	0.0008	0.00166	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FFAR4—obesity	0.000795	0.00165	CbGpPWpGaD
Gonadorelin—Asthenia—Topiramate—obesity	0.000792	0.00172	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—GAL—obesity	0.000781	0.00162	CbGpPWpGaD
Gonadorelin—Pruritus—Topiramate—obesity	0.000781	0.0017	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—GNAS—obesity	0.000781	0.00162	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCK—obesity	0.000778	0.00162	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—C5AR1—obesity	0.000773	0.00161	CbGpPWpGaD
Gonadorelin—Desmopressin—PTGS2—obesity	0.000769	0.0282	CrCbGaD
Gonadorelin—GNRHR—Signaling Pathways—MCHR1—obesity	0.000762	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BRS3—obesity	0.000762	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHSR—obesity	0.000762	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GLP1R—obesity	0.000758	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000758	0.00157	CbGpPWpGaD
Gonadorelin—Diarrhoea—Topiramate—obesity	0.000755	0.00164	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL5—obesity	0.000746	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCKAR—obesity	0.000746	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HRH3—obesity	0.000746	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SH2B1—obesity	0.000708	0.00147	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRLHR—obesity	0.000708	0.00147	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GH1—obesity	0.000708	0.00147	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCK—obesity	0.000707	0.00147	CbGpPWpGaD
Gonadorelin—Vomiting—Topiramate—obesity	0.000702	0.00153	CcSEcCtD
Gonadorelin—Headache—Topiramate—obesity	0.000691	0.0015	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.00069	0.00143	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GLP1R—obesity	0.000689	0.00143	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HRH3—obesity	0.000678	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCKAR—obesity	0.000678	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NPY—obesity	0.000676	0.0014	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000675	0.0014	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IAPP—obesity	0.000672	0.0014	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PYY—obesity	0.000666	0.00138	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APLN—obesity	0.000666	0.00138	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—HTR2A—obesity	0.000658	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—C3—obesity	0.000657	0.00137	CbGpPWpGaD
Gonadorelin—Nausea—Topiramate—obesity	0.000655	0.00143	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PRKAR2B—obesity	0.000652	0.00136	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HTR1B—obesity	0.000652	0.00136	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CRH—obesity	0.000652	0.00136	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PNLIP—obesity	0.000631	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—AGT—obesity	0.000624	0.0013	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NPS—obesity	0.000618	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SDC3—obesity	0.000616	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPY—obesity	0.000614	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IAPP—obesity	0.00061	0.00127	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HTR2C—obesity	0.000606	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—DRD1—obesity	0.000606	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PMCH—obesity	0.000602	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPY5R—obesity	0.000602	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NMU—obesity	0.000602	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HCRT—obesity	0.000602	0.00125	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CRH—obesity	0.000592	0.00123	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HTR1B—obesity	0.000592	0.00123	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB1—obesity	0.000587	0.00122	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MC3R—obesity	0.000577	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MC4R—obesity	0.000577	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPY1R—obesity	0.000577	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPY2R—obesity	0.000577	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—F2—obesity	0.000577	0.0012	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GHRL—obesity	0.000575	0.00119	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—DRD4—obesity	0.00057	0.00118	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPY—obesity	0.000566	0.00118	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NPS—obesity	0.000561	0.00117	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCH—obesity	0.000556	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HDAC8—obesity	0.000556	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GIP—obesity	0.000556	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HTR2C—obesity	0.000551	0.00114	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—DRD1—obesity	0.000551	0.00114	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CNR1—obesity	0.000544	0.00113	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB1—obesity	0.000533	0.00111	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—DRD2—obesity	0.000531	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LEPR—obesity	0.000528	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GCG—obesity	0.000526	0.00109	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—POMC—obesity	0.000526	0.00109	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GHRL—obesity	0.000522	0.00108	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—DRD4—obesity	0.000518	0.00108	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL2—obesity	0.000514	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3CA—obesity	0.000511	0.00106	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CNR1—obesity	0.000494	0.00103	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—DRD2—obesity	0.000482	0.001	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GCG—obesity	0.000477	0.000992	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB2—obesity	0.000476	0.000989	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB3—obesity	0.000473	0.000982	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GAL—obesity	0.000462	0.000959	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000457	0.000951	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—C5AR1—obesity	0.000456	0.000949	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNB3—obesity	0.000453	0.000942	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNAS—obesity	0.000441	0.000917	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB2—obesity	0.000432	0.000898	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCL5—obesity	0.000422	0.000877	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCK—obesity	0.000417	0.000868	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKG1—obesity	0.000417	0.000868	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNB3—obesity	0.000411	0.000855	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RBP4—obesity	0.000407	0.000846	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GLP1R—obesity	0.000407	0.000846	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000405	0.000842	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNAS—obesity	0.000401	0.000833	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCKAR—obesity	0.0004	0.000832	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRH3—obesity	0.0004	0.000832	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKAR2B—obesity	0.000385	0.000801	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL5—obesity	0.000383	0.000796	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCD—obesity	0.00038	0.00079	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NCF2—obesity	0.000372	0.000773	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HTR2A—obesity	0.000372	0.000773	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—C3—obesity	0.000371	0.000772	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPY—obesity	0.000363	0.000754	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOC3—obesity	0.00036	0.000749	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IAPP—obesity	0.00036	0.000749	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AGT—obesity	0.000353	0.000733	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CRH—obesity	0.00035	0.000727	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HTR1B—obesity	0.00035	0.000727	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SDC1—obesity	0.000346	0.000719	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCD—obesity	0.000345	0.000717	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKR1C3—obesity	0.00034	0.000707	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HTR2A—obesity	0.000338	0.000702	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—C3—obesity	0.000337	0.000701	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NPS—obesity	0.000332	0.000689	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2—obesity	0.000326	0.000678	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCB—obesity	0.000326	0.000678	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DRD1—obesity	0.000325	0.000676	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HTR2C—obesity	0.000325	0.000676	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AGT—obesity	0.00032	0.000666	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NTRK2—obesity	0.000316	0.000658	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB1—obesity	0.000315	0.000655	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CG—obesity	0.000312	0.000649	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHRL—obesity	0.000308	0.000641	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PARP1—obesity	0.000308	0.000641	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DRD4—obesity	0.000306	0.000636	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—POMC—obesity	0.000297	0.000617	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—F2—obesity	0.000296	0.000615	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCB—obesity	0.000296	0.000615	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CNR1—obesity	0.000292	0.000607	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TCF7L2—obesity	0.000287	0.000596	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT2—obesity	0.000286	0.000593	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DRD2—obesity	0.000285	0.000592	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CG—obesity	0.000283	0.000589	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTPN1—obesity	0.000282	0.000586	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GCG—obesity	0.000282	0.000586	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CD—obesity	0.000274	0.00057	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—POMC—obesity	0.00027	0.000561	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRL—obesity	0.000269	0.000559	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STK11—obesity	0.000265	0.000551	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL2—obesity	0.000264	0.000548	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLG—obesity	0.000262	0.000545	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—RHOA—obesity	0.000262	0.000544	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT2—obesity	0.000259	0.000539	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3R1—obesity	0.000259	0.000538	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FOXO3—obesity	0.000256	0.000532	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB2—obesity	0.000255	0.00053	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SOCS1—obesity	0.000251	0.000522	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CD—obesity	0.000249	0.000518	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SOCS3—obesity	0.000248	0.000516	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNB3—obesity	0.000243	0.000505	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—TYK2—obesity	0.00024	0.000498	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CB—obesity	0.000239	0.000497	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF2—obesity	0.000239	0.000496	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—RHOA—obesity	0.000238	0.000494	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNAS—obesity	0.000237	0.000492	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3R1—obesity	0.000235	0.000489	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOB—obesity	0.000232	0.000482	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL5—obesity	0.000226	0.00047	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LPL—obesity	0.000221	0.00046	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FOXO1—obesity	0.00022	0.000457	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RPS6KB1—obesity	0.000219	0.000456	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CB—obesity	0.000217	0.000451	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCD—obesity	0.000204	0.000424	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HTR2A—obesity	0.0002	0.000415	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—C3—obesity	0.000199	0.000414	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IRS2—obesity	0.00019	0.000394	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGT—obesity	0.000189	0.000393	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LEP—obesity	0.000185	0.000385	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOE—obesity	0.000185	0.000385	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CAV1—obesity	0.000184	0.000382	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA1—obesity	0.000183	0.000381	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ESR1—obesity	0.000177	0.000368	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2—obesity	0.000175	0.000364	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCB—obesity	0.000175	0.000364	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BAD—obesity	0.000173	0.000359	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CG—obesity	0.000167	0.000348	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IRS1—obesity	0.000165	0.000344	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—POMC—obesity	0.000159	0.000331	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—INS—obesity	0.000158	0.000329	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL2—obesity	0.000156	0.000324	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF1—obesity	0.000153	0.000319	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT2—obesity	0.000153	0.000318	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CD—obesity	0.000147	0.000306	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CA—obesity	0.000146	0.000303	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SERPINE1—obesity	0.000146	0.000302	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TYK2—obesity	0.000142	0.000294	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RHOA—obesity	0.00014	0.000292	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3R1—obesity	0.000139	0.000289	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NOS3—obesity	0.000139	0.000289	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CA—obesity	0.000132	0.000275	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CB—obesity	0.000128	0.000267	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MTOR—obesity	0.000128	0.000267	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—obesity	0.000119	0.000247	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—obesity	0.000117	0.000244	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP9—obesity	0.000111	0.000232	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK8—obesity	0.000108	0.000225	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—obesity	0.000108	0.000225	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT3—obesity	9.91e-05	0.000206	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MYC—obesity	9.21e-05	0.000191	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TGFB1—obesity	9.19e-05	0.000191	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CA—obesity	7.82e-05	0.000163	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—obesity	6.92e-05	0.000144	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—obesity	6.39e-05	0.000133	CbGpPWpGaD
